Literature DB >> 8638069

A polysomnographically documented case of adult somnambulism with long-distance automobile driving and frequent nocturnal violence: parasomnia with continuing danger as a noninsane automatism?

C H Schenck1, M W Mahowald.   

Abstract

A case of childhood-onset somnambulism is reported in which a 43-year-old man presented with repeated sleep-related injuries incurred during violent nocturnal activity, which included frenzied running, throwing punches and wielding knives. He had also driven an automobile a long distance during a presumed somnambulistic state. His wife had been repeatedly injured, and she felt that her life was threatened by his nocturnal violence 2-3 times yearly. Polysomnography (PSG) documented multiple episodes of complex and violent behaviors arising exclusively from stage 3/4 sleep, thus confirming the diagnosis of somnambulism. Other causes of sleep-related violence were excluded. The patient responded promptly to treatment with bedtime clonazepam, and benefit was maintained at 5-year follow-up. Although this strictly clinical case did not have any legal repercussions, it does carry forensic implications, particularly when placed in the context of the published medical literature on PSG-documented parasomnias (somnambulism, rapid eye movement sleep behavior disorder) containing explicit examples of recurrent violence, at times life-threatening, directed toward the bed partner and others. Thus, a new medical-legal concept is proposed, consisting of "parasomnia with continuing danger" as a noninsane automatism. Treatment guidelines, within the context of forensic medicine, are presented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8638069     DOI: 10.1093/sleep/18.9.765

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  10 in total

1.  A series of 8 cases of sleep-related psychogenic dissociative disorders and proposed updated diagnostic criteria.

Authors:  Régis Lopez; Lou Lefevre; Lucie Barateau; Jean-Arthur Micoulaud-Franchi; Yves Dauvilliers; Carlos H Schenck
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

Review 2.  Behavioral parasomnias.

Authors:  Stephen Brooks; Clete A Kushida
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

Review 3.  Hypnosedative-induced complex behaviours : incidence, mechanisms and management.

Authors:  Christian R Dolder; Michael H Nelson
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 5.  Disorders of arousal from sleep and violent behavior: the role of physical contact and proximity.

Authors:  Mark R Pressman
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

6.  A scale for assessing the severity of arousal disorders.

Authors:  Isabelle Arnulf; Bin Zhang; Ginevra Uguccioni; Mathilde Flamand; Alix Noël de Fontréaux; Smaranda Leu-Semenescu; Agnès Brion
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

7.  Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population.

Authors:  M M Ohayon; M W Mahowald; Y Dauvilliers; A D Krystal; D Léger
Journal:  Neurology       Date:  2012-05-15       Impact factor: 9.910

8.  Psychological treatment for sleepwalking: two case reports.

Authors:  Silvia G Conway; Laura Castro; Maria Cecília Lopes-Conceição; Helena Hachul; Sergio Tufik
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Noncontact Sleep Study by Multi-Modal Sensor Fusion.

Authors:  Ku-Young Chung; Kwangsub Song; Kangsoo Shin; Jinho Sohn; Seok Hyun Cho; Joon-Hyuk Chang
Journal:  Sensors (Basel)       Date:  2017-07-21       Impact factor: 3.576

Review 10.  Reticulospinal Systems for Tuning Motor Commands.

Authors:  Robert M Brownstone; Jeremy W Chopek
Journal:  Front Neural Circuits       Date:  2018-04-18       Impact factor: 3.492

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.